Global University Venturing

Lundbeck-backed Iconic Therapeutics, which aims to apply tissue factor biology to retinal disease and cancer treatments, has now raised $80m altogether.

The pharmaceutical company has boosted its stake in mRNA drug developer and strategic partner Moderna to 9%, lifting Moderna's overall funding to at least $790m.

The incubator and workspace provider has secured capital from a consortium featuring return investor University Ventures.

Tsinghua University's investment affiliate has led a series B round for the bicycle maker.

David Ollila, founding director at Northern Michigan University's tech transfer office, has left to join Skypoint Ventures.

Vurb, a contextualised search app that had raised $10m from backers including Stanford University, is set to be acquired by Snapchat in a 75-25 stock-cash deal.

Tioma Therapeutics, an oncology treatment spinout of Washington University in St Louis, has secured funding from backers including Novo, GlaxoSmithKline and Roche.

The report has showed that most venture capital firms that have backed startups in the cleantech sector lost cash.

Pear, the venture firm formerly known as Pejman Mar Ventures, has secured University of Chicago as a limited partner for its $75m second fund.

The university has joined forces with Connecticut Innovations and Webster Bank for a $1.5m fund aimed at local spinouts and startups.

The digital health fund, launched by Astellas Pharma and MPM Capital late last month, will initially look to invest up to $6m in two to three deals per year.